1. Home
  2. TENX vs GYRO Comparison

TENX vs GYRO Comparison

Compare TENX & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • GYRO
  • Stock Information
  • Founded
  • TENX 1967
  • GYRO 1946
  • Country
  • TENX United States
  • GYRO United States
  • Employees
  • TENX N/A
  • GYRO N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • GYRO Building operators
  • Sector
  • TENX Health Care
  • GYRO Real Estate
  • Exchange
  • TENX Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • TENX 19.5M
  • GYRO 19.2M
  • IPO Year
  • TENX N/A
  • GYRO N/A
  • Fundamental
  • Price
  • TENX $5.52
  • GYRO $9.30
  • Analyst Decision
  • TENX Strong Buy
  • GYRO
  • Analyst Count
  • TENX 4
  • GYRO 0
  • Target Price
  • TENX $20.67
  • GYRO N/A
  • AVG Volume (30 Days)
  • TENX 67.4K
  • GYRO 1.4K
  • Earning Date
  • TENX 11-13-2024
  • GYRO 01-01-0001
  • Dividend Yield
  • TENX N/A
  • GYRO N/A
  • EPS Growth
  • TENX N/A
  • GYRO N/A
  • EPS
  • TENX N/A
  • GYRO N/A
  • Revenue
  • TENX N/A
  • GYRO $2,738,019.00
  • Revenue This Year
  • TENX N/A
  • GYRO N/A
  • Revenue Next Year
  • TENX N/A
  • GYRO N/A
  • P/E Ratio
  • TENX N/A
  • GYRO N/A
  • Revenue Growth
  • TENX N/A
  • GYRO N/A
  • 52 Week Low
  • TENX $2.77
  • GYRO $7.65
  • 52 Week High
  • TENX $27.36
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • TENX 52.17
  • GYRO 44.98
  • Support Level
  • TENX $5.70
  • GYRO $8.77
  • Resistance Level
  • TENX $6.01
  • GYRO $9.40
  • Average True Range (ATR)
  • TENX 0.48
  • GYRO 0.08
  • MACD
  • TENX -0.06
  • GYRO -0.00
  • Stochastic Oscillator
  • TENX 17.65
  • GYRO 46.09

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: